GNNSF (Genscript Biotech) Scaled Net Operating Assets : 0.12 (As of Jun. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Genscript Biotech Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Genscript Biotech's operating assets for the quarter that ended in Jun. 2024 was $1,458 Mil. Genscript Biotech's operating liabilities for the quarter that ended in Jun. 2024 was $1,060 Mil. Genscript Biotech's Total Assets for the quarter that ended in Dec. 2023 was $3,387 Mil. Therefore, Genscript Biotech's scaled net operating assets (SNOA) for the quarter that ended in Jun. 2024 was 0.12.

Genscript Biotech Scaled Net Operating Assets Historical Data

The historical data trend for Genscript Biotech's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genscript Biotech Scaled Net Operating Assets Chart

Genscript Biotech Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Scaled Net Operating Assets

Get a 7-Day Free Trial

-0.03

0.47

0.10

0.11

0.21

Genscript Biotech Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Scaled Net Operating Assets	Get a 7-Day Free Trial															-0.06	0.12	0.13	0.16	0.12

Competitive Comparison of Genscript Biotech's Scaled Net Operating Assets

For the Biotechnology subindustry, Genscript Biotech's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genscript Biotech's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genscript Biotech's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Genscript Biotech's Scaled Net Operating Assets falls into.

Genscript Biotech Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Genscript Biotech's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2023 )
=	(Operating Assets (A: Dec. 2023 )	-	Operating Liabilities (A: Dec. 2023 ))	/	Total Assets (A: Dec. 2022 )
=	(1459.252	-	925.958)	/	2546.383
=	0.21

where

	Operating Assets		(A: Dec. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	3387.302	-	1928.05
=	1459.252

	Operating Liabilities		(A: Dec. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	1342.948	-	351.112	-	65.878
=	925.958

Genscript Biotech's Scaled Net Operating Assets (SNOA) for the quarter that ended in Jun. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Jun. 2024 )
=	(Operating Assets (Q: Jun. 2024 )	-	Operating Liabilities (Q: Jun. 2024 ))	/	Total Assets (Q: Dec. 2023 )
=	(1457.932	-	1059.532)	/	3387.302
=	0.12

where

	Operating Assets		(Q: Jun. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	3331.867	-	1873.935
=	1457.932

	Operating Liabilities		(Q: Jun. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	1507.66	-	402.646	-	45.482
=	1059.532

Genscript Biotech Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Genscript Biotech's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Genscript Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genscript Biotech Corp (OTCPK:GNNSF) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

01548:Hong Kong G51:Germany

Address

No. 28, Yongxi Road, Jiangning Science Park, Jiangsu Province, Nanjing, CHN, 211100

Website

https://www.genscript.com

Genscript Biotech Corp is a China-based provider of life science research services and products. it is known for its gene synthesis capabilities, a widely used service by academics, biotech companies, and pharmaceutical companies around the world. Its business lines include life science research services and products, biologics development services under its ProBio brand, and industrial enzymes under its Bestzyme brand. Finally, The company estimates that over two-thirds of GenScript valuation is from its ownership stake in Legend.